{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:24:43Z","timestamp":1773887083907,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.7759\/cureus.38395","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T17:22:39Z","timestamp":1682961759000},"source":"Crossref","is-referenced-by-count":3,"title":["Kaposi\u2019s Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris"],"prefix":"10.7759","author":[{"given":"Jana S","family":"Guenther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Ahronowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Worswick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths WA","year":"1980","unstructured":"Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol. 1980, 5:105-12. 10.1111\/j.1365-2230.1980.tb01676.x","journal-title":"Clin Exp Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1114.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection--type 6 pityriasis rubra pilaris?","volume":"135","author":"Misery I","year":"1996","unstructured":"Misery I, Faure M, Claidy A. Pityriasis rubra pilaris and human immunodeficiency virus infection--type 6 pityriasis rubra pilaris?. Br J Dermatol. 1996, 135:1008-9. 10.1046\/j.1365-2133.1996.d01-1114.x","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13718","article-title":"Systemic therapies of pityriasis rubra pilaris: a systematic review","volume":"17","author":"Kromer C","year":"2019","unstructured":"Kromer C, Sabat R, Celis D, M\u00f6ssner R. Systemic therapies of pityriasis rubra pilaris: a systematic review. J Dtsch Dermatol Ges. 2019, 17:243-59. 10.1111\/ddg.13718","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes D","year":"2020","unstructured":"Haynes D, Strunck JL, Topham CA, et al.. Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial. JAMA Dermatol. 2020, 156:668-75. 10.1001\/jamadermatol.2020.0932","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00367-x","article-title":"Efficacy and safety of ixekizumab through 5 years in moderate-to-severe psoriasis: long-term results from the UNCOVER-1 and UNCOVER-2 phase-3 randomized controlled trials","volume":"10","author":"Leonardi C","year":"2020","unstructured":"Leonardi C, Reich K, Foley P, et al.. Efficacy and safety of ixekizumab through 5 years in moderate-to-severe psoriasis: long-term results from the UNCOVER-1 and UNCOVER-2 phase-3 randomized controlled trials. Dermatol Ther (Heidelb). 2020, 10:431-47. 10.1007\/s13555-020-00367-x","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.169714","article-title":"Kaposi's varicelliform eruption: a case series","volume":"6","author":"Ferrari B","year":"2015","unstructured":"Ferrari B, Taliercio V, Luna P, Abad ME, Larralde M. Kaposi's varicelliform eruption: a case series. Indian Dermatol Online J. 2015, 6:399-402. 10.4103\/2229-5178.169714","journal-title":"Indian Dermatol Online J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12120","article-title":"Kaposi's varicelliform eruption in a patient with pityriasis rubra pilaris (pityriasis rubra pilaris herpeticum)","volume":"27","author":"Cavali\u00e9 M","year":"2013","unstructured":"Cavali\u00e9 M, Giacchero D, Cardot-Leccia N, Passeron T, Lacour JP. Kaposi's varicelliform eruption in a patient with pityriasis rubra pilaris (pityriasis rubra pilaris herpeticum). J Eur Acad Dermatol Venereol. 2013, 27:1585-6. 10.1111\/jdv.12120","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2011.01737.x","article-title":"A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi's varicelliform eruption","volume":"38","author":"Erdag G","year":"2011","unstructured":"Erdag G, Lockman D, Tromberg J, Cropley T, Patterson JW. A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi's varicelliform eruption. J Cutan Pathol. 2011, 38:919-22. 10.1111\/j.1600-0560.2011.01737.x","journal-title":"J Cutan Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80736-0","article-title":"Kaposi\u2019s varicelliform eruption in a patient with pityriasis rubra pilaris","volume":"27","author":"Ng SK","year":"1992","unstructured":"Ng SK, Ang CB, Tham A. Kaposi\u2019s varicelliform eruption in a patient with pityriasis rubra pilaris. J Am Acad Dermatol. 1992, 27:263. 10.1016\/S0190-9622(08)80736-0","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13674","article-title":"Kaposi's varicelliform eruption presenting with extensive skin lesions and sepsis","volume":"44","author":"Fujii M","year":"2017","unstructured":"Fujii M, Takahashi I, Honma M, Ishida-Yamamoto A. Kaposi's varicelliform eruption presenting with extensive skin lesions and sepsis. J Dermatol. 2017, 44:1180-1. 10.1111\/1346-8138.13674","journal-title":"J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/000992288502401118","article-title":"Eczema herpeticum of the child. An unusual manifestation of herpes simplex virus infection","volume":"24","author":"Ingrand D","year":"1985","unstructured":"Ingrand D, Briquet I, Babinet JM, Reinert P, Huraux JM. Eczema herpeticum of the child. An unusual manifestation of herpes simplex virus infection. Clin Pediatr (Phila). 1985, 24:660-3. 10.1177\/000992288502401118","journal-title":"Clin Pediatr (Phila)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.12.005","article-title":"Rapid-onset lichen simplex chronicus after a superinfected herpes simplex virus eruption","volume":"7","author":"Berk-Krauss J","year":"2020","unstructured":"Berk-Krauss J, Mazori DR, Heilman ER, Lowenstein EJ. Rapid-onset lichen simplex chronicus after a superinfected herpes simplex virus eruption. Int J Womens Dermatol. 2020, 7:361-2. 10.1016\/j.ijwd.2020.12.005","journal-title":"Int J Womens Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.07.015","article-title":"Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient","volume":"27","author":"Kranyak A","year":"2022","unstructured":"Kranyak A, Shuler M. Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient. JAAD Case Rep. 2022, 27:55-7. 10.1016\/j.jdcr.2022.07.015","journal-title":"JAAD Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13644","article-title":"Successful treatment of resistant pityriasis rubra pilaris with ixekizumab","volume":"33","author":"Penalba-Torres M","year":"2020","unstructured":"Penalba-Torres M, Pinilla-Mart\u00edn B, Arag\u00f3n-Miguel R, Velasco-Tamariz V, Rivera-D\u00edaz R. Successful treatment of resistant pityriasis rubra pilaris with ixekizumab. Dermatol Ther. 2020, 33:e13644. 10.1111\/dth.13644","journal-title":"Dermatol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000488902","article-title":"Successful treatment of pityriasis rubra pilaris with ixekizumab","volume":"10","author":"Hanfstingl K","year":"2018","unstructured":"Hanfstingl K, Pekar-Lukacs A, Motz R, Guenova E, Hoetzenecker W. Successful treatment of pityriasis rubra pilaris with ixekizumab. Case Rep Dermatol. 2018, 10:97-100. 10.1159\/000488902","journal-title":"Case Rep Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.05.006","article-title":"Successful treatment of type I pityriasis rubra pilaris with ixekizumab","volume":"4","author":"Heibel MD","year":"2018","unstructured":"Heibel MD, Heibel HD. Successful treatment of type I pityriasis rubra pilaris with ixekizumab. JAAD Case Rep. 2018, 4:774-6. 10.1016\/j.jdcr.2018.05.006","journal-title":"JAAD Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01234-17","article-title":"Novel role for interleukin-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal herpes simplex virus 2 vaccination","volume":"91","author":"Bagri P","year":"2017","unstructured":"Bagri P, Anipindi VC, Nguyen PV, Vitali D, St\u00e4mpfli MR, Kaushic C. Novel role for interleukin-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal herpes simplex virus 2 vaccination. J Virol. 2017, 91:e01234-17. 10.1128\/JVI.01234-17","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.075","article-title":"Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses","volume":"36","author":"Stanfield BA","year":"2018","unstructured":"Stanfield BA, Rider PJ, Caskey J, Del Piero F, Kousoulas KG. Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses. Vaccine. 2018, 36:2842-9. 10.1016\/j.vaccine.2018.03.075","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02714-z","article-title":"Herpes simplex and herpes zoster viruses in COVID-19 patients","volume":"191","author":"Katz J","year":"2022","unstructured":"Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci. 2022, 191:1093-7. 10.1007\/s11845-021-02714-z","journal-title":"Ir J Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/150650-kaposis-varicelliform-eruption-after-treatment-with-ixekizumab-in-a-patient-with-pityriasis-rubra-pilaris","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:06Z","timestamp":1707508626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/150650-kaposis-varicelliform-eruption-after-treatment-with-ixekizumab-in-a-patient-with-pityriasis-rubra-pilaris"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.38395","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}